Loading clinical trials...
Loading clinical trials...
Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Retrospective Medical Claims Database Study (Eltrombopag for Aplastic Anemia)
Conditions
Locations
1
United States
Novartis
East Hanover, New Jersey, United States
Start Date
July 14, 2021
Primary Completion Date
May 17, 2024
Completion Date
May 17, 2024
Last Updated
May 28, 2025
NCT02065869
NCT00061763
NCT00578266
NCT00005307
NCT00393380
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions